OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
83 hedge funds and large institutions have $155M invested in Osiris Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
81% less call options, than puts
Call options by funds: $976K | Put options by funds: $5.15M
Holders
83
Holding in Top 10
–
Calls
$976K
Puts
$5.15M
Top Buyers
| 1 | +$3.08M | |
| 2 | +$1.89M | |
| 3 | +$1.75M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.42M |
| 5 |
Morgan Stanley
New York
|
+$1.08M |
Top Sellers
| 1 | -$8.37M | |
| 2 | -$1.52M | |
| 3 | -$299K | |
| 4 |
Citigroup
New York
|
-$231K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$201K |